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A B ST R AC T  
 
Aim: Celiac disease (CD) is a common immune-mediated enteropathy caused by gluten. These 
patients may apply with many different clinical forms. The aim of this study is to determine the 
association of serological tests and type of anemia in CD. 
Methods: Totally117 biopsy proven CD patients aged between 1-17 years were included. Serological 
and hematological parameters of all patients were studied. 
Results: Anemia was identified in 71 (60.7%) cases. Patients with anemia were diagnosed earlier 
than other patients (5.2±4.5 vs. 15.3±33.8 years, p=0.012). Among CD patients with anemia 39 
(54.9%) were having iron deficiency, 22 (30.9%) were having folate deficiency and 10 (14%) were 
having vitamin B 12 deficiency. In patients with tissue transglutaminase (tTG) seropositivity serum 
iron levels and ferritin levels were significantly lower compared to anti-gliadin antibody (AGA) or 
anti-endomysium antibody (EMA) seropositivity  (35±23.5 vs. 57.5±33.3, p=0.007 and 12.4±21.9 vs. 
24.2±18.5, p=0.026, respectively). Low serum folate levels were more frequent in the presence of 
tTG seropositivity compared with AGA+EMA seropositivity (81.8% vs. 25%, p=0.015).  
Conclusions: Anemia is an important cause of admission in CD. These patients are diagnosed earlier 
as a result of anemia. Alone tTG seropositivity is more valuable to demonstrate anemia associated 
with iron or folate deficiencies. 
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Introduction 
Celiac disease (CD) is a systemic chronic 
inflammatory, immune-mediated enteropathy 
caused by permanent intolerance to gluten in 
genetically susceptible individuals. The 
characteristic of this disease is the mucosal 
damage in the small intestine after ingestion of 
gluten-containing foods. The prevalence of CD 
has been estimated to be 0.5–1% [1]. 
Serological tests are mostly used for screening 
purpose. A definite diagnosis is based on 
duodenal biopsy. Characteristic histologic 
abnormalities identified on the mucosa are 
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intraepithelial lymphocyte infiltration, 
mononuclear cell inﬁltration of the lamina 
propria, crypt hyperplasia and varying degrees 
of villous atrophy [2]. 
CD can show many different clinical forms. 
Chronic diarrhea, vomiting, weight loss, 
abdominal pain and abdominal distension are 
present in typical form of CD. The term of 
atypical CD is used for patients who present 
with extraintestinal symptoms like 
dermatological lesions, dental enamel 
hypoplasia, osteoporosis, delayed puberty and 
rickets. Serological positive patients without 
any symptoms is considered as asymptomatic 
form. Latent form of CD covers the subjects 
with genetic predisposition who have initially 
a normal histology despite a gluten-containing 
diet [3]. Among those factors of genetic 
predisposition the most important ones are 
HLA DQ2 and DQ8, which are present in more 
than 95% of CD patients [4]. Early diagnosis 
and treatment of CD prevents the development 
of autoimmune diseases [5] and malignancies 
[6].  
Anemia may be defined as a reduction in blood 
hemoglobin concentration according to age 
[7], and it is a frequent finding in patients with 
CD that usually occurs due to impaired 
absorption of iron, folate, and vitamin B12 
caused by mucosal damage [8]. These reduced 
hemoglobin levels lead to diminished oxygen-
carrying capacity. This effect of anemia is 
harmful for infants and children since it causes 
delay in psychomotor development and 
impaired cognitive performance. Also, it 
increases the morbidity and mortality in these 
age groups [9]. 
The diagnosis of anemia in patients with 
classical CD, who were histologically 
confirmed, is easy. However, publications, 
indicating that biopsy may not be necessary in 
the diagnosis of CD, are increasing in recent 
years [10]. In the absence of typical diarrheal 
presentation, both diagnosis of CD and anemia 
may be delayed. We could not identify any 
study about the relationship between CD 
serology and anemia in the literature. In this 
study, we aimed to investigate the relationship 
between hematologic and serological tests to 
gain early diagnosis of anemia in biopsy-
proven CD patients. 
 
Methods 
The records of all children who were followed 
up with the diagnosis of CD between 2007 and 
2012 in our hospitals were retrospectively 
investigated. The diagnosis of CD was based 
on the criteria defined by the European Society 
for Pediatric Gastroenterology, Hepatology, 
and Nutrition. Genetic assessment (HLA-
DQ2/DQ8) was not performed. Serologic tests 
were investigated in all cases. Biopsies of the 
small intestine were performed for all 
seropositive patients and biopsy specimens 
were evaluated according to Marsh criteria 
[11]. Patients less than 1 year or more than 17 
years of ages or Marsh type 1 were excluded. 
Demographic characteristics of the patients, 
results of laboratory parameters (complete 
blood count, serum iron, ferritin, iron binding 
capacity, folate and vitamin B 12 levels), 
serological tests (anti-gliadin antibody (AGA 
Ig A, IgG), anti-endomysium antibody (EMA 
Ig A, IgG), tissue transglutaminase antibody 
(tTG Ig A, IgG) positivities) were recorded. 
AGA and tTG were checked using an enzyme-
linked immunosorbent assay, whereas EMA 
was evaluated using the immunofluorescent 
method. Serum ferritin, serum folate and 
serum vitamin B 12 levels were studied with 
chemiluminescence assay in all patients. 
Serum iron and serum iron binding capacity 
were studied with the colorimetric method. 
Hemoglobin level <11 g/dL in children aged 6-
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59 months, <11.5 g/dL in children aged 5-11 
years and <12 g/dL in older children were 
considered as anemia.7 The patients with iron 
deficiency anemia (IDA) were having low 
serum iron levels, elevated total iron-binding 
capacity and low ferritin levels [12]. Firstly, 
ferritin level decreases, then total iron binding 
capacity increases when serum iron levels 
decreases and finally serum hemoglobin level 
decreases in IDA [13]. The serum iron levels 
<25 µg/dL in patients younger than 3 years, 
<15 µg/dl in patients between 4‒10 years, and 
<32 µg/dL in patients older than 11 years of 
age for males and <55 µg/dl in patients 
younger than 3 years, <28 µg/dL in patients 
between 4‒10 years, and <25 µg/dl in patients 
older than 11 years of age for females were 
considered as low [14]. The minimum limits 
for serum ferritin levels were considered as 12 
µg/l for patients younger than 5 years of age 
and 15 µg/l for older patients [15]. The 
minimum limit for serum folate levels was 
considered as 3 ng/ml [15]. The minimum limit 
for serum vitamin B12 levels was considered 
as 200 ng/L [16]. 
The statistical analysis was conducted using 
SPSS 15.0 software (SPSS, Inc., Chicago, IL, 
USA). The Student’s t-test, Mann–Whitney U-
test, One-way ANOVA and Kruskal-Wallis 
test were used for the comparisons. p < 0.05 
was considered as significant.   
 
Results 
117 cases were included in this study. Anemia 
was identified in 71 (60.8%) cases. Forty cases 
were female (56.3%).  Mean age was 8.5 ± 5 
years (range, 1–17 years). Forty-five (63.3%) 
were classical form. Twenty-four (33.8%) 
were atypical form.  Two (2.8%) were 
asymptomatic. 
A total of 22 of 26 (84.6%) cases were positive 
for AGA Ig A, 21 of 25 (80.7%) cases were 
positive for AGA Ig G; 22 of 24 (91.6%) cases 
were positive for EMA IgA, 26 of 28 (92.8%) 
cases were positive for EMA IgG and 53 of 54 
(98.1%) cases were positive for tTG IgA, while 
50 of 51 (98%) cases were positive for tTG IgG 
[Table1]. 
 
Table 1. Distribution of serologic tests.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AGA: Anti-gliadin antibody, EMA: Anti-
endomysium antibody, tTG: Tissue 
transglutaminase antibody. 
 
Anemia was identified in 71 (60.7%) cases. 
Hematologic data of all patients are given in 
table 2. Patients with anemia were diagnosed 
earlier (5.2±4.5 vs. 15.3±33.8 years, p=0.012). 
In these patients serum ferritin and serum 
vitamin B 12 levels were significantly lower 
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(13.6±20 vs. 21.4±17, p=0.032 and 343±268 
vs. 446±278, p=0.049, respectively). 
Anemia was found in 50 (59.5%) children and 
21 (63.6%) adolescents with CD, but the 
difference was not statistically significant 
(p=0.68). 
Among CD patients with anemia 39 (54.9%) 
were having iron deficiency, 22 (30.9%) were 
having folate deficiency and 10 (14%) were 
having vitamin B 12 deficiency. 
 
Table 2. Hematological parameters of CD patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IDA was found in 28 (62.2%) of the patients 
with  classical  form,  in  9  (37.5%)  of  the 
patients  with  atypical  form  and  in  2  (100%) 
patients  with asymptomatic form. 
Folate deficiency anemia was found in 16 
(35.5%) of the patients with classical form and 
in 6 (25%) of the patients with atypical form. 
However, there was no statistically significant 
difference between groups regarding presence 
of folate deficiency (p=0.48). 
Vitamin B12 deficiency anemia was found in 
7 (15.5%) of the patients with classical form 
and in 3 (12.5%) of the patients with atypical 
form. However, there was not any statistically 
significant difference between groups 
regarding presence of vitamin B12 deficiency 
(p=0.2). 
Hemoglobin and hematocrit values of these 
patients according to type of anemia was not 
significantly different (p=0.3 and p=0.19, 
respectively). MCV was significantly lower in 
patients with IDA (71.7±5.9 vs. 74.7±7 fl, 
p=0.027), but it was not significantly different 
in patients with folate deficiency (73.4±6.2 vs. 
72.9±6.7 fl, p=0.7) and vitamin B12 deficiency 
(75.5±2.3 vs. 72.9±6.8 fl, p=0.19). Thirteen 
(%32.5) of the patients with folic acid and/or 
vitamin B12 deficiency anemia had also IDA. 
In comparison of patients with positive or 
negative results for EMA IgG; serum 
hemoglobin and hematocrit levels of patients 
with EMA IgG positivity were lower 
(respectively 10.2±1.6  vs. 12.3±2 , p=0.035 
and 31.2±4.9  vs.37.4±5.8 , p=0.038) while 
iron binding capacity was higher (398±104  vs. 
336±19 , p=0.004) compared with EMA IgG 
negative cases.  
In comparison of patients with positive or 
negative tTG IgG; serum ferritin level of 
patients with tTG IgG positivity was lower 
(13±18.7 vs. 30.1±19.1, p=0.044).  
Serum iron was higher in classical form of CD 
compared to asymptomatic form (43±30.9 vs. 
15.8±12.6, p=0.049). Likewise, serum ferritin 
was lower in classical form compared to 
atypical form (14.9±15.8 vs. 28.1±32.9, 
p=0.011). 
When  serological  tests were  analyzed,  just 
AGA  positivity  in  8  patients,  just  EMA 
positivity in 16 patients, just tTG positivity in 
33 patients, AGA+EMA positivity in 4 
patients, AGA + tTG positivity in 13 patients, 
EMA + tTG positivity in 7 patients and AGA 
+ EMA + tTG positivity in 1 patients were 
detected.   
Serum hemoglobin and hematocrit levels were 
higher in patients with AGA seropositivity 
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compared to patients with EMA+tTG 
seropositivity (11.3±1.2 vs. 9.9±1.6, p=0.026 
and 35±4.2 vs.  30.5±5.1, p=0.018, 
respectively). In patients with tTG 
seropositivity serum iron levels and ferritin 
levels were significantly lower compared to 
patients with AGA+EMA seropositivity 
(35±23.5 vs. 57.5±33.3, p=0.007 and 
12.4±21.9 vs. 24.2±18.5, p=0.026, 
respectively).  
 
Table 3. Comparison of serological tests and 
hematological parameters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AGA: Anti-gliadin antibody, EMA: Anti-
endomysium antibody, tTG: Tissue 
transglutaminase antibody. 
In addition, in patients with tTG seropositivity 
serum folate and vitamin B12 levels were 
significantly lower compared to patients with 
AGA+tTG seropositivity (5.5±5.1 vs. 
10.6±6.5, p=0.007 and 279±210 vs. 552±418, 
p=0.002 , respectively). Having serum folate 
level below 3 ng/ml was more frequent in 
patients with tTG seropositivity compared to 
patients with AGA + EMA seropositivity 
(81.8% vs. 25%, p=0.015). Having serum 
vitamin B 12 level below 200 ng/ml was more 
frequent in patients with tTG seropositivity 
compared to patients with AGA + tTG 
seropositivity (48.4% vs. 7.6%, p=0.025) 
[Table 3]. 
 
Discussion 
CD is a major public health problem 
worldwide in children and adolescents. CD is 
diagnosed usually around 2 years of age [17]. 
The timing of introduction of gluten into the 
diet is an important factor in initiation of 
complaints of the disease. However, CD is 
diagnosed to any further extent at a later age in 
recent years. It is suggested probably due to the 
longer usage of breast milk and later 
introduction with gluten [18]. Depending on 
these features, delay in diagnosing CD can be 
more than a decade [19]. In our study, about 
1/3 patients were adolescents. Similar to the 
literature, we found that CD was seen usually 
in females [17,20,21]. 
The diagnosis of classical CD is easy. 
However, CD patients may apply with atypical 
or asymptomatic presentations and diagnosis 
in this group is relatively difficult. Therefore, 
it is thought that more patients may be 
undiagnosed [22]. According to the literature, 
classical CD was diagnosed in 51.3-79% of 
cases, while atypical form was diagnosed in 
21-37.6% of cases and asymptomatic form was 
diagnosed in 15.4% of cases [20,23,24]. 
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Classical CD was also most frequently 
diagnosed in our study while atypical form in 
about 1/3 of cases and asymptomatic form was 
diagnosed in 2.8% of patients. The rate of 
diagnosis of atypical and silent forms of CD 
increased due to the increase in use of serologic 
tests such as the EMA and tTG in recent years 
[20]. 
AGA is unsuitable for diagnosis of CD due to 
low sensitivity and specificity [24] and it is 
used only in under 2 years of age, but the other 
serological tests are used for screening of CD 
in all age groups with high sensitivity [25-28]. 
The tests, except AGA, have sensitivities 
greater than 90% and were considered to 
correlate with the degree of mucosal damage 
[10]. We found  AGA  seropositivity  in  84.6% 
patients,  EMA  seropositivity  in  92.8% 
patients  and  tTG seropositivity  in  98.1% 
patients in our study.  
Anemia in CD patients is diagnosed earlier. 
This is because of failure to thrive due to low 
serum ferritin and vitamin B 12 levels in our 
patients. 
Hematological manifestations of CD are being 
recognized increasingly. The most important 
cause of these disorders is destruction of the 
small intestinal mucosa. Anemia, one of the 
most important manifestations, has been 
determined in 12-69% of CD patients at the 
time of diagnosis [29-31]. Sixty point seven 
percentages of anemia cases that we found in 
our study is consistent with the literature. 
Iron is the essential element for hemoglobin to 
bind oxygen, normal functioning of enzymes 
and immune system. Anemia can lead to 
hypoxemia, failure to thrive and infections 
[32]. Iron is absorbed in the proximal small 
intestine.  
In celiac disease, the mucosal integrity 
deteriorates. So, IDA is usually due to 
increased iron loss or impaired absorption of 
iron in these cases [33]. IDA is a microcytic, 
hypochromic anemia and patients have low 
serum iron levels, elevated total iron-binding 
capacity, and low ferritin levels [12]. IDA is 
common in CD and it is diagnosed in 19-81.6% 
cases [23,24,34]. We found IDA in 54.9% of 
CD cases in our study. 
Folic acid is an essential element for nucleic 
acid metabolism. Inadequate folic acid intake 
leads to impairment hematopoiesis and 
development of the nervous system. It is 
absorbed in the jejunum. Deficiency of folic 
acid usually presents with macrocytic anemia. 
Concomitant iron deficiency can be seen in 
patients with deficiencies of folate and vitamin 
B12 and characteristic macrocytosis may not 
be detected in these cases as in our study [35]. 
Folate deficiency anemia is reported in 10-
42% of CD patients [21,23,36,37]. Thirty point 
nine percentage of folate deficiency anemia 
that we found in our study is consistent with 
the literature.  
Vitamin B12 is another essential element for 
nucleic acid metabolism. This type of anemia 
shows that distal small intestine where is the 
only absorption place of vitamin B12 is 
affected in these patients [38]. Laboratory 
findings similar to folate deficiency except for 
normal serum folate and low serum B 12 
vitamin levels. Vitamin B 12 deficiency 
anemia is diagnosed in 5-41% of CD patients 
[21,23,36,37]. Fourteen percentage of vitamin 
B 12 deficiency anemia that we found in our 
study is consistent with the literature. 
The anemia can also be seen due to 
malabsorption of some micronutrients like 
copper or zinc in CD [39].  
Frequency of diagnosis of IDA can vary 
according to the form of CD. IDA was more 
frequently reported in children with classical 
CD when compared with atypical form [20]. 
We found similar results. However, the 
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incidence of other types of anemia did not 
differ according to the form of CD. 
Kuloglu et al [22] reported iron-deficiency 
anemia in 89%, folate deficiency anemia in 
19.6% and vitamin B 12 deficiency anemia in 
7.6% of patients with classical CD. These rates 
were 62.2%, 35.5% and 15.5% in our study. 
Kuloglu et al [23] reported iron-deficiency 
anemia in 67.6%, folate deficiency anemia in 
16.6% and vitamin B 12 deficiency anemia in 
9.5% of patients with atypical form of CD. 
These rates were 37.5%, 25% and 12.5% in our 
study. 
Delay in the diagnosis of CD causes worsening 
of anemia. Iwanczak et al [20] reported anemia 
more frequently in adults than in children. We 
found similar result in our study, but it was not 
statistically significant. 
Serum hemoglobin and hematocrit values were 
found to be lower in patients with AGA 
seropositivity than patients with EMA+tTG 
seropositivity. These results were regarded as 
quite interesting by us due to the less 
sensitivity of AGA seropositivity in the 
diagnosis of CD in recent years. 
We found a significant relationship between 
EMA IgG or tTG IgG and IDA. Particularly, 
patients positive for these parameters should 
be monitored more closely for the presence of 
IDA. 
We found IDA more frequently than 
megaloblastic anemia due to vitamin B 12 or 
folate deficiencies in patients with tTG 
seropositivity. Particularly, patients positive 
for this parameters should be monitored more 
closely for the presence of vitamin B 12 or 
folate deficiencies. 
In conclusion, anemia is an important cause of 
admission in CD. These patients are diagnosed 
earlier as a result of anemia. Alone tTG 
seropositivity is more valuable to demonstrate 
anemia associated with iron, folate or vitamin 
B 12 deficiencies than the single or combined 
use of other serological tests. 
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